Metabolic effects of growth hormone therapy in an Alström syndrome patient

Hormone Research

Volumn 60, Issue 6, 2003, Pages 297-301

  Tai, Tsai Sung ^a   Lin, Shih Yi ^b   Sheu, Wayne Huey Herng ^b  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Acanthosis nigricans; Alstr m syndrome; Growth hormone; Insulin resistance

Indexed keywords

HUMAN GROWTH HORMONE; METFORMIN;

ACANTHOSIS NIGRICANS; ADOLESCENT; ALSTROM SYNDROME; ANAMNESIS; ARTICLE; BODY COMPOSITION; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ENZYME BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; HYPERGLYCEMIA; INSULIN SENSITIVITY; LABORATORY TEST; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

ABNORMALITIES, MULTIPLE; ACANTHOSIS NIGRICANS; ADIPOSE TISSUE; ADOLESCENT; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; CHROMOSOME DISORDERS; DIAGNOSTIC TESTS, ROUTINE; FATTY LIVER; GENES, RECESSIVE; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; HYPERINSULINISM; HYPERTRIGLYCERIDEMIA; METABOLISM; SYNDROME; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0345491544     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074248     Document Type: Article

References (31)

1. Macari F, Lautier C, Girardet A, Dadoun F, Darmon P, Dutour A, Renard E, Bouvagnet P, Claustres M, Oliver C, Grigorescu F: Refinement of genetic localization of the Alström syndrome on chromosome 2p12-13 by linkage analysis in a North African family. Hum Genet 1998;103:658-661.
2. Collin GB, Marshall JD, Ikeda A, So WV, Russell-Eggitt I, Maffei P, Beck S, Boerkoel CF, Sicolo N, Martin M, Nishina PM, Naggert JK: Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome. Nat Genet 2002;31:74-78.
3. Marshall JD, Ludman MD, Shea SE, Salisbury SR, Willi SM, LaRoche RG, Nishina PM: Genealogy, natural history, and phenotype of Alström syndrome in a large Acadian kindred and three additional families. Am J Med Genet 1997;73:150-161.
4. Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkebaek NE, Hilsted J: Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab 1995;80:1407-1415.
5. Argente J, Caballo N, Barrios V, Pozo J, Muñoz MT, Chowen JA, Hernandez M: Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: Effect of short- and long-term weight reduction. J Clin Endocrinol Metab 1997;82:2076-2083.
6. Johannsson G, Mårin P, Lönn L, Ottsson M, Stenlöf K, Björntorp P, Sjöström L, Bengtsson BÅ: Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab 1997;82:727-734.
7. Kamel A, Norgren S, Elimam A, Danielsson P, Marcus C: Effects of growth hormone treatment in obese prepubertal boys. J Clin Endocrinol Metab 2000;85:1412-1419.
8. Salomon F, Cuneo RC, Umpleby AM, Sönksen PH: Interactions of body fat and muscle mass with substrate concentrations and fasting insulin levels in adults with growth hormone deficiency. Clin Sci (Colch) 1994;87:201-206.
9. Al-Shoumer KA, Page B, Thomas E, Murphy M, Beshyah SA, Johnston DG: Effects of four years' treatment with biosynthetic human growth hormone (GH) on body composition in GH-deficient hypopituitary adults. Eur J Endocrinol 1996;135:559-567.
10. Hwu CM, Kwok CF, Lai TY, Shih KC, Lee TS, Hsiao LC, Lee SH, Fang VS, Ho LT: Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: A report of one-year clinical experience. J Clin Endocrinol Metab 1997;82:3285-3292.
11. Hussain MA, Schmitz O, Mengel A, Glatz Y, Christiansen JS: Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans. J Clin Invest 1994;94:1126-1133.
12. Yang S, Björntorp P, Liu X, Eden S: Growth hormone treatment of hypophysectomized rats increases catecholamine-induced lipolysis and the number of β-adrenergic receptors in adipocytes: No differences in the effects of growth hormone on different fat depots. Obes Res 1996;4:471-478.
13. Alter CA, Moshang T Jr: Growth hormone deficiency in two siblings with Alström syndrome. Am J Dis Child 1993;147:97-99.
14. Sheldon WR Jr, DeBold CR, Evans WS, DeCherney GS, Jackson RV, Island DP, Thorner MO, Orth DN: Rapid sequential intravenous administration of four hypothalamic releasing hormones as a combined anterior pituitary function test in normal subjects. J Clin Endocrinol Metab 1985;60:623-630.
15. Wass JA: Hypopituitarism; in Besser GM, Cudworth AG (eds): Clinical Endocrinology: An Illustrated Text. Philadelphia, Lippincott, 1987, pp 1-14.
16. Lanes R, Hurtado E: Oral clonidine - an effective growth hormone-releasing agent in prepubertal subjects. J Pediatr 1982;100:710-714.
17. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI: Assessment of fat free mass using bioelectrical impedance measurements of human body. Am J Clin Nutr 1985;41:810-817.
18. Satman I, Yilmaz MT, Gürsoy N, Karşidaǧ K, Dinççaǧ N, Ovali T, Karadeniz Ş, Uysal V, Buǧra Z, Ökten A, Devrim S: Evaluation of insulin resistant diabetes mellitus in Alström syndrome: A long-term prospective follow-up of three siblings. Diabetes Res Clin Pract 2002; 56:189-196.
19. Ricci C, Longo R, Gioulis E, Bosco M, Pollesello P, Masutti F, Croce LS, Paoletti S, de Bernard B, Tiribelli C, Dalla Palma L: Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 1997;27:108-113.
20. Sheu WH, Lee WJ, Chen YT: Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects. Am J Hypertens 2000;13:14-20.
21. Seminara S, Merello G, Masi S, Filpo A, La Cauza F, D'Onghia G, Martelli E, Loche S: Effect of long-term growth hormone treatment on carbohydrate metabolism in children with growth hormone deficiency. Clin Endocrinol (Oxf) 1998;49:125-130.
22. Al-Shoumer KA, Gray R, Anyaoku V, Hughes C, Beshyah S, Richmond W, Johnston DG: Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clin Endocrinol (Oxf) 1998;48:795-802.
23. Lund S, Flyvbjerg A, Holman GD, Larsen FS, Pedersen O, Schmitz O: Comparative effects of IGF-I and insulin on the glucose transporter system in rat muscle. Am J Physiol 1994;267:E461-E466.
24. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N: Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450-455.
25. Osono Y, Nakajima K, Hata Y: Hypertriglyceridemia and fatty liver: Clinical diagnosis of fatty liver and lipoprotein profiles in hypertrigly-ceridemic patients with fatty liver. J Atheroscler Thromb 1995;2(suppl 1):47S-52S.
26. Goto T, Onuma T, Takebe K, Kral JG: The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 1995;19:841-845.
27. Holder M, Hecker W, Gilli G: Impaired glucose tolerance leads to delayed diagnosis of Alström syndrome. Diabetes Care 1995;18:698-700.
28. Connolly MB, Jan JE, Couch RM, Wong LT, Dimmick JE, Rigg JM: Hepatic dysfunction in Alström syndrome. Am J Med Genet 1991;40:421-424.
29. Awazu M, Tanaka T, Sato S, Anzo M, Higuchi M, Yamazaki K, Matsuo N: Hepatic dysfunction in two sibs with Alström syndrome: case report and review of the literature. Am J Med Genet 1997;69:13-16.
30. Garry P, Collins P, Devlin JG: An open 36-month study of lipid changes with growth hormone in adults: Lipid changes following replacement of growth hormone in adult acquired hormone deficiency. Eur J Endocrinol 1996;134:61-66.
31. Cruz PD Jr, Hud JA Jr: Excess insulin binding to insulin-like growth factor receptors: Proposed mechanism for acanthosis nigricans. J Invest Dermatol 1992;98(6 suppl):82S-85S.